SAREPTA THERAPEUTICS, INC. (SRPT) Capital expenditures 2016–2025
SAREPTA THERAPEUTICS, INC. (SRPT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$102.0MFY2025 · since FY2016: $5.3M → $102.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $102.0M | -25.5% |
| FY2024 | $137.0M | +80.0% |
| FY2023 | $76.1M | +146.9% |
| FY2022 | $30.8M | -19.9% |
| FY2021 | $38.5M | -53.2% |
| FY2020 | $82.2M | +37.9% |
| FY2019 | $59.6M | -2.5% |
| FY2018 | $61.2M | +409.6% |
| FY2017 | $12.0M | +124.7% |
| FY2016 | $5.3M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice